Home > Insider Trading > Filing (0001181431-13-054430)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1125345	Macrogenics Inc	MGNX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1567045	Kenneth Galbraith	C/O Macrogenics, Inc. 9640 Medical Center Drive Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-16	46,875	$16.00	46,875	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-10-16	1,050,652	$0.00	1,097,527	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2013-10-16	204,207	$0.00	1,301,734	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2013-10-16	15,315	$0.00	1,317,049	No	4	X	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	X	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Convertible Preferred Stock	Disposition	2013-10-16	19,724,839	$0.00	1,050,652	$0.00
Common Stock	Series D-2 Convertible Preferred Stock	Disposition	2013-10-16	3,833,767	$0.00	204,207	$0.00
Common Stock	Series D-2 Convertible Preferred Warrants	Disposition	2013-10-16	287,533	$0.00	15,315	$0.00

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Indirect
	No	4	C	Indirect
2013-10-16	No	4	X	Indirect

Footnotes

These securities are held by Five Corners Capital, Inc. Kenneth Galbraith is Managing Director of Five Corners Capital, Inc. Kenneth Galbraith disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Each share of Series C Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock converted into approximately 0.0533 of a share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These securities are held by Ventures West 8 Limited Partnership. Kenneth Galbraith is Managing Director of Five Corners Capital, Inc., the general partner of Ventures West 8 Limited Partnership. Kenneth Galbraith disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
Upon exercise, each Series D-2 Convertible Preferred Warrant converted into an equal number of shares of Series D-2 Convertible Preferred Stock. Had the warrants not been exercised, they would have expired upon the closing of the initial public offering. Upon the closing of the Issuer's initial public offering each share of Series D-2 Convertible Preferred Stock then converted into approximately 0.0533 of a share of Common Stock without payment of further consideration. The shares of Series D-2 Convertible Preferred Stock had no expiration date.
Immediately.